Reviva Pharmaceuticals Priced An Underwritten Offering Of 4.76M Shares (Or Pre-funded Warrants In Lieu Thereof) And Investor Warrants To Purchase Up To 4.76M Shares, Combined Price Of Each Share And Accompanying Warrant Is $1.05 And Each Pre-funded...
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.